Daniel A. Rushing

Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma

Lara E. Davis, Vanessa Bolejack, Christopher W. Ryan et al. · Journal of Clinical Oncology · 2019 · 262 citations · Full text

Medicine, Oncology, Pharmacology +17

Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior Chemotherapy

George D. Demetri, Sant P. Chawla, Isabelle Ray‐Coquard et al. · Journal of Clinical Oncology · 2013 · 242 citations

Medicine, Oncology, Pharmacology +17

Doxorubicin clearance in the obese.

Keith A. Rodvold, Daniel A. Rushing, Duane A. Tewksbury · Journal of Clinical Oncology · 1988 · 211 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Gastrointestinal stromal tumors: CT and MRI findings

Kumaresan Sandrasegaran, Arumugam Rajesh, Daniel A. Rushing et al. · European Radiology · 2005 · 210 citations

Medicine, Oncology, Radiology +14

Gastrointestinal Stromal Tumors: Clinical, Radiologic, and Pathologic Features

Kumaresan Sandrasegaran, Arumugam Rajesh, Jonas Rydberg et al. · American Journal of Roentgenology · 2005 · 140 citations · Full text

Medicine, Oncology, Pathology +17